Although dual-energy absorptiometry (DXA) has proven its clinical utility, there are many limitations to using areal bone mineral density (aBMD) measured by DXA to predict bone strength and fracture risk. Recent advances in imaging techniques including quantitative computed tomography (QCT) and magnetic resonance imaging (MRI) have led to non-invasive assessment of bone macro-architecture and micro-architecture. Analysis techniques such as finite element (FE) modelling use image data to estimate the ability of a bone to carry load, and provide new insight into treatment effects and fracture risk. QCT and MRI can image clinically relevant sites such as the lumbar spine and proximal femur. High-resolution peripheral QCT (HR-pQCT) offers superior resolution at peripheral sites including the radius and tibia. Measures obtained from QCT and HRpQCT have been significantly associated with fracture risk independently of DXA-derived parameters. FE models derived from QCT, HR-pQCT, and MRI are capable of detecting treatment-induced changes in bone strength, and preliminary results suggest that QCT and HR-pQCT-derived FE models can discriminate fracture cases from controls.Continued advances in image acquisition and analysis will improve our ability to predict fracture and to understand factors associated with bone strength.